Top HighYield Savings Accounts Offer Up to 41 APY on May 24 2026 Federal Cannabis Rescheduling Could Lift Tax Burden Potentially Unlocking Billions for Industry Josh Harts Resurgence Fuels New York Knicks Postseason Momentum ADP Report Shows Private Payrolls Rose 109000 in April Exceeding Expectations AnheuserBusch InBev Shares Edge Lower as Revenue Misses Analyst Forecasts Broadcom AVGO Among Steve Cohens Top Stock Picks What Investors Should Know HLT Q1 2026 Earnings EPS Beats Estimates by 117 Amid Modest Stock Decline COSM Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges IVR Q1 2026 Earnings Mortgage REIT Slightly Misses EPS Estimates Amid Market Volatility CVNA Q1 2026 Earnings EPS Surprises to the Upside Stock Rallies Weyco Group Q1 2026 Earnings Steady EPS Performance Amid Challenging Retail Environment Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by 416 as Stock Edges Higher Spectral AI Inc MDAI Edges Higher Nearing Key Resistance as Momentum Shifts Dave Inc DAVE Pushes Higher Nears Key Resistance at 26907 UNITIL Corporation UTL Holds Steady Near Support as Utility Sector Consolidates First Trust Preferred Income Fund FPF Edges Higher Amid Steady Income Appeal BXP Inc Holds Steady Near 60 Support and Resistance Levels in Focus Perpetua Resources Secures 29 Billion US ExportImport Bank Loan for Idaho Gold and Antimony Project CHH Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction Unum Group UNM Slips 095 as Stock Consolidates Near MidRange BellRing Brands BRBR Q1 2026 Earnings EPS Miss of 565 Triggers Slight Stock Decline MCW Q1 2026 Earnings EPS Surpasses Estimates with 144 Beat American Eagle Outfitters AEO Q1 2026 Earnings EPS Surges Past Estimates Shares Edge Higher GLXY Q1 2026 Earnings EPS Misses Estimates Amid Crypto Market Volatility Daily Journal Corp DJCO Q4 2025 Earnings EPS Surges to 3061 on Investment Gains Stock Edges Higher Fortress Biotech Preferred Stock FBIOP Q4 2025 Earnings EPS Misses Estimates by Over 108 Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline